Holen Sie sich die Stockscreener-App
3.09
2.22%
-0.07
Exagen Inc Aktie (XGN) Neueste Nachrichten
Exagen stock price target lowered to $10 by Canaccord on margin outlook - Investing.com UK
KeyBanc cuts Exagen stock price target on pricing headwinds - Investing.com Nigeria
Exagen (XGN): Canaccord Genuity Lowers Price Target to $10.00 | - GuruFocus
Canaccord Genuity Group Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat
Exagen Inc. 2025 Annual Report: Innovative AVISE® Autoimmune Disease Testing, Business Strategy, Pipeline, and Intellectual Property Overview - Minichart
Analyst John Wilkin Lowers Price Target for Exagen (XGN) | XGN S - GuruFocus
Exagen (NASDAQ:XGN) Price Target Cut to $10.00 by Analysts at Craig Hallum - MarketBeat
XGN: Keybanc Lowers Price Target to $10, Maintains Overweight Ra - GuruFocus
KeyCorp Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat
KeyBanc cuts Exagen stock price target on pricing headwinds By Investing.com - Investing.com UK
Exagen stock price target lowered to $10 by Canaccord on margin outlook By Investing.com - Investing.com Canada
Exagen outlines $70M–$73M 2026 revenue target while expanding sales force and innovation cadence - MSN
BTIG cuts Exagen stock price target to $9 on lower revenue outlook By Investing.com - Investing.com India
William Blair Maintains Outperform on Exagen Inc. (XGN) March 2026 - Meyka
Exagen (XGN) Rating Maintained by BTIG, Price Target Lowered to $9.00 | XGN Stock News - GuruFocus
BTIG cuts Exagen stock price target to $9 on lower revenue outlook - Investing.com UK
Exagen (NASDAQ:XGN) Price Target Lowered to $9.00 at BTIG Research - MarketBeat
Exagen Inc (XGN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Investments By GuruFocus - Investing.com Canada
Exagen Inc (XGN) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Investments - GuruFocus
4 Analysts Have This To Say About Exagen - Benzinga
Exagen stock maintains Outperform rating at William Blair By Investing.com - Investing.com India
Exagen Q4 2025 Earnings Call Transcript - MarketBeat
Exagen Inc. Reports Strong Q4 and Full-Year 2025 Financial Results – Earnings Press Release March 2026 - Minichart
Exagen Q4 Earnings Call Highlights - Yahoo Finance
Exagen (XGN) Achieves Record Q4 Revenue, Driven by Test Volume G - GuruFocus
XGN Forecasts Significant Revenue Growth by 2026 - GuruFocus
Earnings call transcript: Exagen Inc. misses Q4 2025 earnings expectations - Investing.com Nigeria
Exagen 2025 10-K: Revenue $66.6M; net loss $(19.95)M - TradingView
Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook - ChartMill
Exagen Inc. (XGN) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Exagen (NASDAQ:XGN) Releases Quarterly Earnings Results, Hits Estimates - MarketBeat
EXAGEN DIAGNOSTICS ($XGN) Releases Q4 2025 Earnings - Quiver Quantitative
Exagen reports record 2025 revenue $66.6M, ASP rises to $441; Q4 revenue $16.6M - TradingView
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results - The Manila Times
Exagen Earnings Report: Q4 Overview - Benzinga
Exagen Inc. (XGN) Posts Fourth Quarter Loss, Surpasses Revenue Projections - Bitget
A Peek at Exagen's Future Earnings - Benzinga
XGN: B. Riley Securities Lowers Price Target, Maintains Buy Rati - GuruFocus
Aug Spikes: How strong is Exagen Inc. stock balance sheetTrade Analysis Summary & AI Enhanced Trade Execution Alerts - Naître et grandir
Exagen Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
Exagen Inc. (NASDAQ:XGN) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Exagen Inc. (NASDAQ:XGN) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
John Aballi Sells 15,698 Shares of Exagen (NASDAQ:XGN) Stock - MarketBeat
Exagen CEO Aballi sells $56,826 in shares - Investing.com Nigeria
Exagen CEO Aballi sells $56,826 in shares By Investing.com - Investing.com India
Exagen (XGN) CEO Aballi covers RSU taxes and buys shares via ESPP - Stock Titan
XGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Exagen Inc. to Participate in Upcoming Investor Conferences - The Manila Times
CEO Change: Will Exagen Inc benefit from geopolitical trendsTreasury Yields & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Exagen (XGN) to Release Earnings on Tuesday - MarketBeat
Exagen Inc. (NASDAQ:XGN) Short Interest Update - MarketBeat
XGN Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Insider Selling: Exagen (NASDAQ:XGN) CEO Sells 11,430 Shares of Stock - MarketBeat
EXAGEN (XGN) CEO has 11,430 shares sold to cover RSU tax withholding - Stock Titan
Exagen (NASDAQ:XGN) Price Target Cut to $10.00 by Analysts at TD Cowen - Defense World
TD Cowen Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - MarketBeat
Exagen (XGN) Rating Maintained, Price Target Lowered by TD Cowen - GuruFocus
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 - GlobeNewswire
Exagen: A Deep Dive into the Diagnostics Specialist's Fundamentals - AD HOC NEWS
What are Exagen Inc.’s recent SEC filings showingJuly 2025 Drop Watch & Low Risk Profit Maximizing Plans - mfd.ru
RTW INVESTMENTS, LP Reduces Stake in Exagen Inc: A Strategic Por - GuruFocus
How interest rate cuts could boost Exagen Inc. stockWeekly Investment Summary & Daily Momentum Trading Reports - mfd.ru
1.05%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):